Teleflex Incorporated (TFX) To Go Ex-Dividend on May 20th

Teleflex Incorporated (NYSE:TFX) announced a quarterly dividend on Monday, May 12th, RTT News reports. Shareholders of record on Tuesday, May 20th will be given a dividend of 0.34 per share by the medical technology company on Monday, June 16th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.05%. The ex-dividend date of this dividend is Tuesday, May 20th.

Teleflex has a dividend payout ratio of 9.7% indicating that its dividend is sufficiently covered by earnings. Analysts expect Teleflex to earn $15.18 per share next year, which means the company should continue to be able to cover its $1.36 annual dividend with an expected future payout ratio of 9.0%.

Teleflex Stock Up 2.1%

Teleflex stock opened at $129.15 on Friday. The firm has a market cap of $5.71 billion, a price-to-earnings ratio of 25.67, a PEG ratio of 1.73 and a beta of 1.17. The stock has a fifty day simple moving average of $132.83 and a two-hundred day simple moving average of $162.64. Teleflex has a 12 month low of $120.06 and a 12 month high of $249.91. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37.

Teleflex (NYSE:TFX) last posted its earnings results on Thursday, May 1st. The medical technology company reported $2.91 EPS for the quarter, topping analysts’ consensus estimates of $2.88 by $0.03. The business had revenue of $700.67 million during the quarter, compared to analyst estimates of $699.37 million. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. The company’s quarterly revenue was down 5.0% compared to the same quarter last year. During the same quarter last year, the company earned $3.21 EPS. Equities analysts predict that Teleflex will post 13.98 EPS for the current fiscal year.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Teleflex stock. Empowered Funds LLC lifted its stake in shares of Teleflex Incorporated (NYSE:TFX) by 15.8% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,684 shares of the medical technology company’s stock after acquiring an additional 230 shares during the quarter. Empowered Funds LLC’s holdings in Teleflex were worth $233,000 at the end of the most recent reporting period. 95.62% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of research firms have commented on TFX. Needham & Company LLC reissued a “hold” rating on shares of Teleflex in a report on Wednesday, March 12th. Morgan Stanley cut their price objective on Teleflex from $191.00 to $173.00 and set an “overweight” rating for the company in a report on Monday, May 5th. Bank of America lowered Teleflex from a “neutral” rating to an “underperform” rating and cut their price objective for the stock from $235.00 to $140.00 in a report on Tuesday, March 4th. Citizens Jmp lowered Teleflex from an “outperform” rating to a “market perform” rating in a report on Thursday, February 27th. Finally, Truist Financial decreased their price target on shares of Teleflex from $140.00 to $137.00 and set a “hold” rating on the stock in a research report on Monday, May 5th. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $164.63.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.